The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.
申请公布号
WO2015038939(A2)
申请公布日期
2015.03.19
申请号
WO2014US55458
申请日期
2014.09.12
申请人
ISIS PHARMACEUTICALS, INC.
发明人
GROSSMAN, TAMAR, R.;MCCALEB, MICHAEL, L.;WATT, ANDREW, T.;FREIER, SUSAN, M.
